ArticleClinical case reports2026
Lead Toxicity Associated With Over-The-Counter Slimming Supplements: A Case Report.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lead poisoning is rarely seen in clinical practice nowadays. However, the widespread promotion of dietary supplements can lead to cases of lead toxicity, presenting with symptoms such as abdominal colic, neuropsychiatric issues, and anemia. Here, we present a case of a 28-year-old male who developed lead poisoning after consuming Garcinia cambogia for weight loss. Any unexplained symptom, such as abdominal pain, may be attributable to lead poisoning. The cornerstone of diagnosis of lead poisoning lies in meticulous history taking of any supplements and confirmation with blood lead levels. Discontinuing the offending supplement is the mainstay of management. Lead chelation with penicillamine should be considered for blood lead levels above 50 μg/dL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.